Compare ALEMBIC PHARMA with Biocon - Equitymaster

Helping You Build Wealth With Honest Research
Since 1996. Try Now

  • MyStocks

MEMBER'S LOGINX

     
Login Failure
   
     
   
     
 
 
 
(Please do not use this option on a public machine)
 
     
 
 
 
  Sign Up | Forgot Password?  

ALEMBIC PHARMA vs BIOCON - Comparison Results

BIOCON  
   Change

Biocon is India's largest biotechnology company with presence in biopharmaceuticals, custom research and clinical research. It started as an enzymes manufacturer and later evolved into an integrated biopharmaceutical company. The company has two subs... More

DO YOU LIKE THESE REPORTS? TELL US!

Current Valuations

    ALEMBIC PHARMA BIOCON ALEMBIC PHARMA/
BIOCON
 
P/E (TTM) x 16.4 31.8 51.6% View Chart
P/BV x 6.5 3.8 172.2% View Chart
Dividend Yield % 0.6 0.3 225.0%  

Financials

 ALEMBIC PHARMA   BIOCON
EQUITY SHARE DATA
    ALEMBIC PHARMA
Mar-19
BIOCON
Mar-19
ALEMBIC PHARMA/
BIOCON
5-Yr Chart
Click to enlarge
High Rs664707 93.9%   
Low Rs412554 74.5%   
Sales per share (Unadj.) Rs208.791.9 227.1%  
Earnings per share (Unadj.) Rs31.016.7 185.5%  
Cash flow per share (Unadj.) Rs37.124.2 153.5%  
Dividends per share (Unadj.) Rs5.501.00 550.0%  
Dividend yield (eoy) %1.00.2 644.4%  
Book value per share (Unadj.) Rs144.2101.6 141.9%  
Shares outstanding (eoy) m188.52600.00 31.4%   
Bonus / Rights / Conversions ---  
Price / Sales ratio x2.66.9 37.6%   
Avg P/E ratio x17.437.7 46.0%  
P/CF ratio (eoy) x14.526.1 55.6%  
Price / Book Value ratio x3.76.2 60.2%  
Dividend payout %17.76.0 296.5%   
Avg Mkt Cap Rs m101,461378,330 26.8%   
No. of employees `000NA6.1 0.0%   
Total wages/salary Rs m7,46711,653 64.1%   
Avg. sales/employee Rs ThNM8,994.3-  
Avg. wages/employee Rs ThNM1,900.7-  
Avg. net profit/employee Rs ThNM1,635.3-  
INCOME DATA
Net Sales Rs m39,34755,144 71.4%  
Other income Rs m941,444 6.5%   
Total revenues Rs m39,44156,588 69.7%   
Gross profit Rs m8,73615,883 55.0%  
Depreciation Rs m1,1524,478 25.7%   
Interest Rs m184709 26.0%   
Profit before tax Rs m7,49312,140 61.7%   
Minority Interest Rs m119 120.0%   
Prior Period Items Rs m-930-   
Extraordinary Inc (Exp) Rs m00-   
Tax Rs m1,5682,123 73.8%   
Profit after tax Rs m5,84410,026 58.3%  
Gross profit margin %22.228.8 77.1%  
Effective tax rate %20.917.5 119.6%   
Net profit margin %14.918.2 81.7%  
BALANCE SHEET DATA
Current assets Rs m19,57748,228 40.6%   
Current liabilities Rs m14,89630,376 49.0%   
Net working cap to sales %11.932.4 36.7%  
Current ratio x1.31.6 82.8%  
Inventory Days Days9068 131.4%  
Debtors Days Days4586 53.0%  
Net fixed assets Rs m27,09764,130 42.3%   
Share capital Rs m3773,000 12.6%   
"Free" reserves Rs m26,81157,980 46.2%   
Net worth Rs m27,18860,980 44.6%   
Long term debt Rs m4,99315,766 31.7%   
Total assets Rs m47,778121,924 39.2%  
Interest coverage x41.718.1 230.1%   
Debt to equity ratio x0.20.3 71.0%  
Sales to assets ratio x0.80.5 182.1%   
Return on assets %12.68.8 143.3%  
Return on equity %21.516.4 130.7%  
Return on capital %23.616.8 140.9%  
Exports to sales %028.1 0.0%   
Imports to sales %018.9 0.0%   
Exports (fob) Rs mNA15,506 0.0%   
Imports (cif) Rs mNA10,399 0.0%   
Fx inflow Rs m19,45315,506 125.5%   
Fx outflow Rs m6,06510,399 58.3%   
Net fx Rs m13,3885,107 262.1%   
CASH FLOW
From Operations Rs m8,12011,546 70.3%  
From Investments Rs m-7,556-7,138 105.9%  
From Financial Activity Rs m590-2,417 -24.4%  
Net Cashflow Rs m1,1532,103 54.8%  

Share Holding

Indian Promoters % 74.1 40.4 183.4%  
Foreign collaborators % 0.0 20.6 -  
Indian inst/Mut Fund % 2.9 8.4 34.5%  
FIIs % 9.1 10.7 85.0%  
ADR/GDR % 0.0 0.0 -  
Free float % 13.9 19.9 69.8%  
Shareholders   49,328 109,995 44.8%  
Pledged promoter(s) holding % 0.0 0.0 -  
NM: Not Meaningful
Source: Company Annual Reports, Regulatory Filings, Equitymaster

Compare ALEMBIC PHARMA With:   J.B.CHEMICALS  SUVEN LIFE SCIENCES  ORCHID PHARMA  AJANTA PHARMA  FULFORD INDIA  

Compare ALEMBIC PHARMA With:   ADCOCK INGRAM (S. Africa)  MYLAN (US)  ACTAVIS (US)  TEVA PHARMA (Israel)  



Today's Market

5 Reasons Why Sensex Zoomed 613 Points Today(Closing)

Indian share markets extended gains as the session progressed and ended on a strong note.

Related Views on News

BIOCON Announces Quarterly Results (3QFY21); Net Profit Down 19.7% (Quarterly Result Update)

Jan 25, 2021 | Updated on Jan 25, 2021

For the quarter ended December 2020, BIOCON has posted a net profit of Rs 2 bn (down 19.7% YoY). Sales on the other hand came in at Rs 19 bn (up 5.9% YoY). Read on for a complete analysis of BIOCON 's quarterly results.

ALEMBIC PHARMA Announces Quarterly Results (3QFY21); Net Profit Up 13.8% (Quarterly Result Update)

Jan 19, 2021 | Updated on Jan 19, 2021

For the quarter ended December 2020, ALEMBIC PHARMA has posted a net profit of Rs 3 bn (up 13.8% YoY). Sales on the other hand came in at Rs 13 bn (up 8.7% YoY). Read on for a complete analysis of ALEMBIC PHARMA's quarterly results.

BIOCON Announces Quarterly Results (2QFY21); Net Profit Down 23.9% (Quarterly Result Update)

Oct 29, 2020 | Updated on Oct 29, 2020

For the quarter ended September 2020, BIOCON has posted a net profit of Rs 2 bn (down 23.9% YoY). Sales on the other hand came in at Rs 17 bn (up 11.0% YoY). Read on for a complete analysis of BIOCON 's quarterly results.

ALEMBIC PHARMA Announces Quarterly Results (2QFY21); Net Profit Up 30.0% (Quarterly Result Update)

Oct 23, 2020 | Updated on Oct 23, 2020

For the quarter ended September 2020, ALEMBIC PHARMA has posted a net profit of Rs 3 bn (up 30.0% YoY). Sales on the other hand came in at Rs 15 bn (up 17.4% YoY). Read on for a complete analysis of ALEMBIC PHARMA's quarterly results.

BIOCON Announces Quarterly Results (3QFY20); Net Profit Up 1.2% (Quarterly Result Update)

Jan 24, 2020 | Updated on Jan 24, 2020

For the quarter ended December 2019, BIOCON has posted a net profit of Rs 2 bn (up 1.2% YoY). Sales on the other hand came in at Rs 17 bn (up 13.5% YoY). Read on for a complete analysis of BIOCON 's quarterly results.

More Views on News

Most Popular

Is Intraday Trading For You?(Fast Profits Daily)

May 13, 2021

Do you think you have what it takes to be an intraday trader? Find out in this video.

My Secret to Find Breakthrough Stocks(Fast Profits Daily)

May 7, 2021

I've used this trading technique for many years with great success. I'm sharing it with you today.

Are the Stock Markets Deaf to Covid Agony?(Profit Hunter)

May 6, 2021

Why are markets discounting the economic impact of Covid?

The Key to Profit from India's EV Revolution(Profit Hunter)

May 7, 2021

Stocks you must consider investing in before buying your first electric vehicle.

More

India's #1 Trader
Reveals His Secrets

Secret To Increasing Your Trading Profits Today
Get this Special Report,
The Secret to Increasing Your Trading Profits Today, Now!
We will never sell or rent your email id.
Please read our Terms

ALEMBIC PHARMA SHARE PRICE


May 18, 2021 03:36 PM

TRACK ALEMBIC PHARMA

  • Track your investment in ALEMBIC PHARMA with Equitymaster's Portfolio Tracker. Set live price alerts, get research alerts and more. Get access now...
  • Add To MyStocks

MORE ON ALEMBIC PHARMA

ALEMBIC PHARMA 8-QTR ANALYSIS

COMPARE ALEMBIC PHARMA WITH

MARKET STATS